Search Results

There are 16821 results for: content related to: Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation

  1. You have free access to this content
    Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease

    Cancer

    Volume 121, Issue 16, August 15, 2015, Pages: 2713–2719, Florence K. Keane, Ming-Hui Chen, Danjie Zhang, Brian J. Moran, Michelle H. Braccioforte and Anthony V. D'Amico

    Version of Record online : 29 APR 2015, DOI: 10.1002/cncr.29420

  2. You have free access to this content
    Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners

    Cancer

    Volume 121, Issue 24, December 15, 2015, Pages: 4286–4299, Kristine A. Donovan, Lauren M. Walker, Richard J. Wassersug, Lora M. A. Thompson and John W. Robinson

    Version of Record online : 15 SEP 2015, DOI: 10.1002/cncr.29672

  3. You have free access to this content
    Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

    CA: A Cancer Journal for Clinicians

    Volume 60, Issue 3, May/June 2010, Pages: 194–201, Glenn N. Levine, Anthony V. D'Amico, Peter Berger, Peter E. Clark, Robert H. Eckel, Nancy L. Keating, Richard V. Milani, Arthur I. Sagalowsky, Matthew R. Smith and Neil Zakai

    Version of Record online : 3 FEB 2010, DOI: 10.3322/caac.20061

  4. You have free access to this content
    Long-term impact of androgen-deprivation therapy on physical function and quality of life

    Cancer

    Volume 121, Issue 14, July 15 2015, Pages: 2350–2357, Shabbir M. H. Alibhai, Henriette Breunis, Narhari Timilshina, Gary Naglie, Ian Tannock, Murray Krahn, Padraig Warde, Neil E. Fleshner, Sarah Duff Canning and George Tomlinson

    Version of Record online : 24 MAR 2015, DOI: 10.1002/cncr.29355

  5. Androgen deprivation therapy's impact on the mood of prostate cancer patients as perceived by patients and the partners of patients

    Psycho-Oncology

    Volume 25, Issue 7, July 2016, Pages: 848–856, Dexter Van Dam, Richard J. Wassersug and Lisa Dawn Hamilton

    Version of Record online : 31 AUG 2015, DOI: 10.1002/pon.3932

  6. You have free access to this content
    A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

    BJU International

    Volume 107, Issue 6, March 2011, Pages: 924–928, Howard S. Kim, Daniel M. Moreira, Matthew R. Smith, Joseph C. Presti Jr, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling and Stephen J. Freedland

    Version of Record online : 22 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09679.x

  7. You have free access to this content
    Androgen deprivation and thromboembolic events in men with prostate cancer

    Cancer

    Volume 118, Issue 13, 1 July 2012, Pages: 3397–3406, Behfar Ehdaie, Coral L. Atoria, Amit Gupta, Andrew Feifer, William T. Lowrance, Michael J. Morris, Peter T. Scardino, James A. Eastham and Elena B. Elkin

    Version of Record online : 9 NOV 2011, DOI: 10.1002/cncr.26623

  8. Risk of new-onset diabetes after androgen deprivation therapy for prostate cancer in the Asian population

    Journal of Diabetes

    Volume 7, Issue 5, September 2015, Pages: 672–680, Jeremy Yuen Chun Teoh, Peter Ka Fung Chiu, Samson Yun Sang Chan, Darren Ming Chun Poon, Ho-Yuen Cheung, Simon See Ming Hou and Chi-Fai Ng

    Version of Record online : 22 DEC 2014, DOI: 10.1111/1753-0407.12226

  9. You have free access to this content
    Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer

    Cancer

    Volume 120, Issue 11, 1 June 2014, Pages: 1620–1629, Mack Roach III

    Version of Record online : 3 MAR 2014, DOI: 10.1002/cncr.28594

  10. You have free access to this content
    Hydrogen sulfide protects blood–brain barrier integrity following cerebral ischemia

    Journal of Neurochemistry

    Volume 129, Issue 5, June 2014, Pages: 827–838, Yali Wang, Jia Jia, Guizhen Ao, Lifang Hu, Hui Liu, Yunqi Xiao, Huaping Du, Nabil J. Alkayed, Chun-Feng Liu and Jian Cheng

    Version of Record online : 27 MAR 2014, DOI: 10.1111/jnc.12695

  11. Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer

    Cancer

    Volume 123, Issue 2, January 15, 2017, Pages: 237–244, Shabbir M.H. Alibhai, Narhari Timilshina, Sarah Duff-Canning, Henriette Breunis, Ian F. Tannock, Gary Naglie, Neil E. Fleshner, Murray D. Krahn, Padraig Warde, Shireen Marzouk and George A. Tomlinson

    Version of Record online : 1 SEP 2016, DOI: 10.1002/cncr.30320

  12. Evidence for reduced neuromuscular function in men with a history of androgen deprivation therapy for prostate cancer

    Clinical Physiology and Functional Imaging

    Volume 34, Issue 3, May 2014, Pages: 209–217, Danielle Girard, Frank E. Marino and Jack Cannon

    Version of Record online : 30 SEP 2013, DOI: 10.1111/cpf.12084

  13. You have free access to this content
    Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer

    BJU International

    Volume 116, Issue 3, September 2015, Pages: 358–365, David R. Ziehr, Ming-Hui Chen, Danjie Zhang, Michelle H. Braccioforte, Brian J. Moran, Brandon A. Mahal, Andrew S. Hyatt, Shehzad S. Basaria, Clair J. Beard, Joshua A. Beckman, Toni K. Choueiri, Anthony V. D'Amico, Karen E. Hoffman, Jim C. Hu, Neil E. Martin, Christopher J. Sweeney, Quoc-Dien Trinh and Paul L. Nguyen

    Version of Record online : 29 OCT 2014, DOI: 10.1111/bju.12905

  14. You have free access to this content
    Risk of acute myocardial infarction after androgen-deprivation therapy for prostate cancer in a Chinese population

    BJU International

    Volume 116, Issue 3, September 2015, Pages: 382–387, Jeremy Y.C. Teoh, Samson Y.S. Chan, Peter K.F. Chiu, Darren M.C. Poon, Ho-Yuen Cheung, Simon S.M. Hou and Chi-Fai Ng

    Version of Record online : 7 MAR 2015, DOI: 10.1111/bju.12967

  15. Approach for estimating the dynamic physical thresholds of phytoplankton production and biomass in the tropical-subtropical Pacific Ocean

    Journal of Geophysical Research: Biogeosciences

    Volume 122, Issue 6, June 2017, Pages: 1385–1403, E. Gómez-Ocampo, G. Gaxiola-Castro and Reginaldo Durazo

    Version of Record online : 15 JUN 2017, DOI: 10.1002/2016JG003636

  16. Prostate cancer treatments and their side effects are associated with increased insomnia

    Psycho-Oncology

    Volume 22, Issue 6, June 2013, Pages: 1381–1388, Josée Savard, Séverine Hervouet and Hans Ivers

    Version of Record online : 8 AUG 2012, DOI: 10.1002/pon.3150

  17. Androgen Deprivation Therapy for Prostate Cancer: Recommendations to Improve Patient and Partner Quality of Life

    The Journal of Sexual Medicine

    Volume 7, Issue 9, September 2010, Pages: 2996–3010, Stacy Elliott, David M. Latini, Lauren M. Walker, Richard Wassersug, John W. Robinson and the ADT Survivorship Working Group

    Version of Record online : 7 JUL 2010, DOI: 10.1111/j.1743-6109.2010.01902.x

  18. Evaluation of the effectiveness of adding androgen deprivation to modern dose-escalated radiotherapy for men with favorable intermediate-risk prostate cancer

    Cancer

    Volume 122, Issue 15, August 1, 2016, Pages: 2341–2349, Aaron D. Falchook, Ramsankar Basak, Jahan J. Mohiuddin and Ronald C. Chen

    Version of Record online : 18 MAY 2016, DOI: 10.1002/cncr.30049

  19. You have free access to this content
    Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer

    Cancer

    Volume 121, Issue 15, August 1, 2015, Pages: 2603–2611, Rana R. McKay, Kathryn P. Gray, Julia H. Hayes, Glenn J. Bubley, Jonathan E. Rosenberg, Arif Hussain, Philip W. Kantoff and Mary-Ellen Taplin

    Version of Record online : 22 APR 2015, DOI: 10.1002/cncr.29398

  20. Race and mortality risk after radiation therapy in men treated with or without androgen-suppression therapy for favorable-risk prostate cancer

    Cancer

    Volume 122, Issue 23, December 1, 2016, Pages: 3608–3614, Konstantin A. Kovtun, Ming-Hui Chen, Michelle H. Braccioforte, Brian J. Moran and Anthony V. D'Amico

    Version of Record online : 4 AUG 2016, DOI: 10.1002/cncr.30224